n-(4-hydroxyphenyl)all-trans retinamide Report issue

Small molecule Experimental
AACT ChEMBL DrugBank PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)Nc2ccc(O)cc2)C(C)(C)CCC1
  • InChIKey: AKJHMTWEGVYYSE-FXILSDISSA-N
  • Mol. Mass: 391.56
  • ALogP: 6.86
  • ChEMBL Molecule:
    fenretinide  
More Chemistry

Pharmacology

Alternative names

4-hpr | 4-hydroxy(phenyl)retinamide | fenretinide | fenretinidev | mcn-r-1967 | n-(4-hydroxyphenyl)all-trans retinamide

Organizations (38)

Research & Development (38)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (43)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (43)


 

Brain Neoplasms (Phase 2)

Breast Neoplasms (Phase 3)

Burkitt Lymphoma (Phase 1/Phase 2)

Cognition (Phase 3)

Cystic Fibrosis (Phase 1)

Geographic Atrophy (Phase 2)

Glioblastoma (Phase 2)

Gliosarcoma (Phase 2)

Hamartoma (Phase 2)

Head and Neck Neoplasms (Phase 2)

Hodgkin Disease (Phase 1/Phase 2)

Insulin Resistance (Phase 2)

Kidney Neoplasms (Phase 2)

Leukemia (Phase 1)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1/Phase 2)

Leukemia-Lymphoma, Adult T-Cell (Phase 1/Phase 2)

Leukemia, Myeloid, Acute (Phase 1)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 1)

Lymphoma, B-Cell, Marginal Zone (Phase 1/Phase 2)

Lymphoma, Follicular (Phase 1/Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 1/Phase 2)

Lymphoma, Large-Cell, Immunoblastic (Phase 1/Phase 2)

Lymphoma, Mantle-Cell (Phase 1/Phase 2)

Lymphoma, Non-Hodgkin (Phase 1)

Lymphoma, Primary Cutaneous Anaplastic Large Cell (Phase 1/Phase 2)

Lymphoma, T-Cell, Peripheral (Phase 2)

Macular Degeneration (Phase 2)

Melanoma (Phase 2)

Multiple Myeloma (Phase 1)

Myeloproliferative Disorders (Phase 1)

Neoplasms (Phase 3)

Neuroblastoma (Phase 2)

Obesity (Phase 2)

Ovarian Neoplasms (Phase 2)

Precancerous Conditions (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Prostatic Neoplasms (Phase 2)

Psychotic Disorders (Phase 3)

Schizophrenia (Phase 3)

Urinary Bladder Neoplasms (Phase 3)

Uterine Cervical Neoplasms (Phase 3)

Waldenstrom Macroglobulinemia (Phase 1/Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 42
  • # of Trial Organizations: 38

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue